evenfolioETF Details
Emerald Mutual Fund Advisers Trust·Health·LFSC · Nasdaq
F/M Emerald Life Sciences Innovation ETF (LFSC)
- Price
- $43.60
- —30 Oct 2026
- Assets
- $123.4M
- Total net assets
- Expense ratio
- 0.54%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 35.5%+6.7%
- Category 28.8%
- 3Y CAGR
- —
- Category 21.5%
- 5Y CAGR
- —
- Category 4.1%
Loading NAV history…
F/M Emerald Life Sciences Innovation ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -2.2% | -4.3% | +14.3% | +19.1% | +35.5% | — | — | — | +32.4% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -5.8% | -14.2% | -8.7% | -1.4% | +6.7% | — | — | — | +20.8% |
Holdings
The 10 largest positions make up 52.1% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| CORT | Corcept Therapeutics Inc | 7.05% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 6.70% |
| LIVN | LivaNova PLC | 6.54% |
| COGT | Cogent Biosciences Inc | 6.11% |
| SYRE | Spyre Therapeutics Inc | 5.16% |
| BLLN | BillionToOne Inc Ordinary Shares - Class A | 4.67% |
| GH | Guardant Health Inc | 4.41% |
| REPL | Replimune Group Inc | 4.38% |
| MANE | Veradermics Inc | 3.64% |
| MIRM | Mirum Pharmaceuticals Inc | 3.44% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.7
- P/S
- 6.5
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.5%
- Bonds0.6%
Credit quality
Share of the bonds by rating.
- US government0.6%
ETF details
- Issuer
- Emerald Mutual Fund Advisers Trust
- Category
- Equity · Health
- Ticker
- LFSC
- Exchange
- Nasdaq
- Inception
- 30 Oct 2024 (2.0 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.54% (category 1.00%)
- Holdings turnover
- 19% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 0.00
- Total net assets
- $123.4M
- Average duration
- 0.77 years
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- IBBQ · Invesco Nasdaq Biotechnology ETFInvesco · $103.3M · ER 0.19%5Y 8.7%
- GNOM · Global X Genomics & Biotechnology ETFGlobal X Funds · $102.9M · ER 0.50%5Y -3.8%
- AGNG · Global X Aging Population ETFGlobal X Funds · $88.9M · ER 0.50%5Y 6.8%
- HTEC · ROBO Global Healthcare Technology and Innovation ETFRobo Global · $76.3M · ER 0.68%5Y -0.3%
- OZEM · Roundhill GLP-1 & Weight Loss ETFRoundhill Investments · $57.8M · ER 0.59%
- HRTS · Tema Heart & Health ETFTema ETFs · $53.7M · ER 0.75%